{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:44:45Z","timestamp":1648871085519},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1331\/japha.2015.14220","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T16:38:10Z","timestamp":1422031090000},"page":"118","source":"Crossref","is-referenced-by-count":0,"title":["Causes and root causes of a multistate fungal meningitis outbreak"],"prefix":"10.1016","volume":"55","author":[{"given":"Earlene E.","family":"Lipowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Thomas Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2015.14220_bb0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1331\/JAPhA.2014.14011","article-title":"How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak","volume":"54","author":"Teshome","year":"2014","journal-title":"J Am Pharm Assoc"},{"key":"10.1331\/JAPhA.2015.14220_bb0015","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2146\/ajhp050447","article-title":"Impact of United States Pharmacopeia chapter 797: results of a national survey","volume":"63","author":"Candy","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"10.1331\/JAPhA.2015.14220_bb0020","first-page":"170","article-title":"Economic and technological drivers of generic sterile injectable drug shortages","volume":"93","author":"Woodcock","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1331\/JAPhA.2015.14220_bb0025","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2146\/ajhp130127","article-title":"Discretion of the Food and Drug Administration to enforce compounding rules","volume":"70","author":"Lie","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1331\/JAPhA.2015.14220_bb0030","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1377\/hlthaff.2013.0832","article-title":"Switching to less expensive blindness drug could save Medicare Part B $18 billion over a ten-year period","volume":"33","author":"Hutton","year":"2014","journal-title":"Health Aff (Millwood)"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115300297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115300297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T14:20:21Z","timestamp":1582554021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115300297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1544319115300297"],"URL":"https:\/\/doi.org\/10.1331\/japha.2015.14220","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}